These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 25371019)

  • 1. Epidemiology, disease burden and outcomes of cirrhosis in a large secondary care hospital in South Auckland, New Zealand.
    Hsiang JC; Bai WW; Raos Z; Stableforth W; Upton A; Selvaratnam S; Gane EJ; Gerred SJ
    Intern Med J; 2015 Feb; 45(2):160-9. PubMed ID: 25371019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural history of chronic hepatitis B: a retrospective study.
    Wu GC; Zhou WP; Zhao YR; Guo SH; Wang ZY; Zou SB; Zhang QH; Ren H; Huang AL; Zhang DF
    Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):566-70. PubMed ID: 14627521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probability of liver cancer and survival in HCV-related or alcoholic-decompensated cirrhosis. A study of 377 patients.
    Solà R; Alvarez MA; Ballesté B; Montoliu S; Rivera M; Miquel M; Cirera I; Morillas RM; Coll S; Planas R
    Liver Int; 2006 Feb; 26(1):62-72. PubMed ID: 16420511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.
    Beste LA; Leipertz SL; Green PK; Dominitz JA; Ross D; Ioannou GN
    Gastroenterology; 2015 Nov; 149(6):1471-1482.e5; quiz e17-8. PubMed ID: 26255044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
    Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N
    Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.
    Marot A; Henrion J; Knebel JF; Moreno C; Deltenre P
    PLoS One; 2017; 12(10):e0186715. PubMed ID: 29077714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 2 diabetes: a risk factor for liver mortality and complications in hepatitis B cirrhosis patients.
    Hsiang JC; Gane EJ; Bai WW; Gerred SJ
    J Gastroenterol Hepatol; 2015 Mar; 30(3):591-9. PubMed ID: 25250942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
    Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK
    Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014.
    Kim D; Cholankeril G; Li AA; Kim W; Tighe SP; Hameed B; Kwo PY; Harrison SA; Younossi ZM; Ahmed A
    Liver Int; 2019 Sep; 39(9):1661-1671. PubMed ID: 31081997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant reduction in end-stage liver diseases burden through the national viral hepatitis therapy program in Taiwan.
    Chiang CJ; Yang YW; Chen JD; You SL; Yang HI; Lee MH; Lai MS; Chen CJ
    Hepatology; 2015 Apr; 61(4):1154-62. PubMed ID: 25476749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis.
    Bengtsson B; Stål P; Wahlin S; Björkström NK; Hagström H
    Liver Int; 2019 Jun; 39(6):1098-1108. PubMed ID: 30829446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment.
    Margini C; Dufour JF
    Liver Int; 2016 Mar; 36(3):317-24. PubMed ID: 26601627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma incidence in noncirrhotic patients with chronic hepatitis B and patients with cirrhosis of all etiologies.
    Do AL; Wong CR; Nguyen LH; Nguyen VG; Trinh H; Nguyen MH
    J Clin Gastroenterol; 2014 Aug; 48(7):644-9. PubMed ID: 24201999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma.
    Mahmood S; Niiyama G; Kamei A; Izumi A; Nakata K; Ikeda H; Suehiro M; Kawanaka M; Togawa K; Yamada G
    Liver Int; 2005 Apr; 25(2):220-5. PubMed ID: 15780042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of chronic hepatitis C patients treated with interferon-alpha: risk of cirrhosis and hepatocellular carcinoma in a single center over 10 years.
    Lee HJ; Yeon JE; Yoon EL; Suh SJ; Kang K; Kim HR; Kang SH; Yoo YJ; Je J; Kim JH; Seo YS; Yim HJ; Byun KS
    Intervirology; 2015; 58(1):14-21. PubMed ID: 25592614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.
    N'Kontchou G; Paries J; Htar MT; Ganne-Carrie N; Costentin L; Grando-Lemaire V; Trinchet JC; Beaugrand M
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1062-8. PubMed ID: 16844421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatocellular carcinoma: the significance of cirrhosis for treatment and prognosis--retrospective study].
    Witjes CD; de Man RA; Eskens FA; Dwarkasing RS; Zondervan PE; Verhoef C; Ijzermans JN
    Ned Tijdschr Geneeskd; 2010; 154():A1747. PubMed ID: 20719013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiological, clinical and therapeutic features of hepatocellular carcinoma in cirrhotic patients].
    Said Y; Debbeche R; Ben Ali Z; Bouzid K; Trabelsi S; Bouzaidi S; Salem M; Rajhi H; Kouni Chahed M; Najjar T
    Tunis Med; 2012 Jun; 90(6):468-72. PubMed ID: 22693088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Characteristics of Patients with Liver Cirrhosis Visiting a Tertiary Hospital over 15 Years: a Retrospective Multi-Center Study in Korea.
    Jang WY; Chung WJ; Jang BK; Hwang JS; Lee HJ; Hwang MJ; Kweon YO; Tak WY; Park SY; Lee SH; Lee CH; Kim BS; Kim SH; Suh JI; Park JG
    J Korean Med Sci; 2020 Jul; 35(29):e233. PubMed ID: 32715667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic and extrahepatic malignancies in cirrhosis caused by nonalcoholic steatohepatitis and alcoholic liver disease.
    Kodama K; Tokushige K; Hashimoto E; Taniai M; Shiratori K
    Alcohol Clin Exp Res; 2013 Jan; 37 Suppl 1():E247-52. PubMed ID: 23320802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.